ACXP Acurx Pharmaceuticals, Inc. - Common Stock
$1,87
Preço · Mai 20, 2026
Fundamentais a partir de Mai 11, 2026
Intervalo 52 Semanas
$1–$21
3% of range
Classificação do Analista
BUY
9 analysts
Preço-Alvo
$17
+809% upside
P/E (TTM)
-0.5
ROE
-180.3%
Margem de Lucro Líquido
—
ACXP Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$1.87
Capitalização de Mercado
$6M
P/E (TTM)
-0.5
EPS (TTM)
$-5.32
Receita (TTM)
—
Rendimento div.
—
ROE
-180.3%
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $21
ACXP Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
—
EPS
$-5.32
2020-12-31
→
2025-12-31
Fluxo de caixa livre
—
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
ACXP
Mediana de Pares
P/E (TTM)
-0.5
—
P/B
1.1
1.0
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
ACXP
Mediana de Pares
ROA
-138.0%
-89.8%
ROE
-180.3%
-215.6%
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
ACXP
Mediana de Pares
Quick Ratio (Índice de Liquidez Seca)
3.1
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
ACXP
Mediana de Pares
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
ACXP
Mediana de Pares
ACXP Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
9 analistas
- Compra forte 2 22,2%
- Compra 6 66,7%
- Manter 1 11,1%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
3 analistas · 2026-05-15
Mediana
$10.00
Média
$17.00
← Abaixo de todos os alvos
$1.87
Mín
$10.00
Máx
$31.00
Alvo mediano
$10.00
+434,8%
Alvo médio
$17.00
+809,1%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.42%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-0.62 | $-0.65 | 0.03% |
| 31 de Dezembro de 2025 | $-0.31 | $-1.01 | 0.70% |
| 30 de Setembro de 2025 | $-1.23 | $-1.34 | 0.11% |
| 30 de Junho de 2025 | $-1.89 | $-2.31 | 0.42% |
| 31 de Março de 2025 | $-2.20 | $-3.06 | 0.86% |
Comparação com pares Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
| GNPX | $6M | — | — | — | -347.0% | — |
| PMCB | $8M | 0.4 | — | — | 66.5% | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| BIAF | — | — | — | — | — | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| XBIO | — | -1.4 | 19.0% | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $5M | $6M | $5M | $2M | $2M | |
| SG&A Expense | $6M | $9M | $9M | $7M | $11M | · | |
| Operating Expenses | $8M | $14M | $15M | $12M | $13M | $5M | |
| Operating Income | $-8M | $-14M | · | · | · | · | |
| Interest Income | $125.4K | $20.1K | · | · | · | · | |
| Income Tax | · | · | · | $0 | · | $0 | |
| Net Income | $-8M | $-14M | $-15M | $-12M | $-13M | $-5M | |
| EPS (Basic) | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 | $-0.74 | |
| EPS (Diluted) | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 | $-0.74 | |
| Shares (Basic) | 1,498,793 | 808,168 | 12,671,572 | 10,816,412 | 8,535,873 | 6,190,875 | |
| Shares (Diluted) | 1,498,793 | 808,168 | 12,671,572 | 10,816,412 | 8,535,873 | 6,190,875 | |
| EBITDA | $-8M | · | · | · | · | · |
Balanço Patrimonial 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $4M | $7M | $9M | $13M | $3M | |
| Prepaid Expense | $85.0K | $100.1K | $105.8K | $265.0K | $295.3K | $48.6K | |
| Current Assets | · | $4M | $8M | $9M | $13M | · | |
| Total Assets | $8M | $4M | $8M | $9M | $13M | $3M | |
| Accounts Payable | $2M | $3M | $3M | $2M | $843.9K | $455.9K | |
| Current Liabilities | $2M | $3M | $3M | $2M | $843.9K | $472.6K | |
| Total Liabilities | $2M | $3M | $3M | $2M | $843.9K | $522.4K | |
| Common Stock | $2.3K | $852 | $14.5K | $11.6K | $10.2K | · | |
| Paid-in Capital | $81M | $68M | $58M | $46M | $39M | · | |
| Retained Earnings | $-75M | $-67M | $-53M | $-39M | $-27M | $-14M | |
| Stockholders' Equity | $5M | $615.1K | $5M | $7M | $12M | $3M | |
| Liabilities + Equity | $8M | $4M | $8M | $9M | $13M | $3M | |
| Shares Outstanding | 2,348,113 | 851,534 | 723,411 | 11,627,609 | 10,215,792 | 0 |
Fluxo de Caixa 6
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $3M | $3M | $3M | $5M | $695.8K | |
| Operating Cash Flow | $-7M | $-10M | $-10M | $-8M | $-5M | $-3M | |
| Stock Issued | · | · | · | $4M | · | · | |
| Net Stock Activity | · | · | · | $4M | · | · | |
| Financing Cash Flow | $11M | $7M | $8M | $4M | $15M | $4M | |
| Net Change in Cash | $4M | $-4M | $-2M | $-4M | $10M | $692.1K |
Lucratividade 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -138.0% | -243.8% | -170.6% | -106.9% | -154.7% | · | |
| ROE | -180.3% | -860.2% | -339.0% | -141.6% | · | · |
Liquidez e Solvência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Quick Ratio | 3.1 | 1.1 | 2.5 | 4.4 | 15.4 | · |
Avaliação (TTM) 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-8M | $-14M | $-15M | $-12M | $-13M | · | |
| Market Cap | $6M | $277M | $1.11B | $926M | $883M | · | |
| P/E | -0.5 | -0.9 | -66.6 | -71.1 | -58.0 | · | |
| P/B | 1.1 | 450.7 | 237.5 | 126.5 | · | · | |
| P / Tangible Book | 1.1 | 450.7 | 237.5 | 126.5 | 71.1 | · | |
| P / Cash Flow | -0.9 | -26.7 | -113.1 | -122.7 | -176.1 | · | |
| Earnings Yield | -213.6% | -107.2% | -1.5% | -1.4% | -1.7% | · |
Demonstração de Resultados 12
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $341.5K | $281.8K | $429.7K | $524.2K | $598.8K | $825.1K | $1M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $2M | $911.7K | |
| SG&A Expense | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | · | · | · | · | · | · | · | · | |
| Interest Income | $35.0K | $38.8K | $35.9K | $23.4K | $27.3K | $12.0K | $5.0K | $782 | · | · | · | · | · | · | · | · | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | $-5M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | |
| EPS (Basic) | $-0.62 | $-2.09 | $-1.23 | $-1.89 | $-2.15 | $-8.51 | $-3.45 | $-5.21 | $-0.28 | $-0.38 | $-0.24 | $-0.28 | $-0.25 | $-0.28 | $-0.32 | $-0.26 | |
| EPS (Diluted) | $-0.62 | $-2.09 | $-1.23 | $-1.89 | $-2.15 | $-8.51 | $-3.45 | $-5.21 | $-0.28 | $-0.38 | $-0.24 | $-0.28 | $-0.25 | $-0.28 | $-0.32 | $-0.26 | |
| Shares (Basic) | 2,718,433 | -21,355,926 | 1,625,805 | 1,190,266 | 1,001,932 | -16,273,746 | 818,174 | 791,233 | 15,472,507 | -24,159,432 | 13,005,128 | 12,186,481 | 11,639,395 | -20,828,035 | 11,148,402 | 10,263,202 | |
| Shares (Diluted) | 2,718,433 | -21,355,926 | 1,625,805 | 1,190,266 | 1,001,932 | -16,273,746 | 818,174 | 791,233 | 15,472,507 | -24,159,432 | 13,005,128 | 12,186,481 | 11,639,395 | -20,828,035 | 11,148,402 | 10,263,202 | |
| EBITDA | $-2M | · | $-2M | $-2M | · | · | · | · | · | · | · | · | · | · | · | · |
Balanço Patrimonial 13
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $8M | $6M | $6M | $5M | $4M | $6M | $6M | $9M | $7M | $7M | $9M | $7M | $9M | $11M | $9M | |
| Prepaid Expense | $228.8K | $85.0K | $158.2K | $53.5K | $161.6K | $100.1K | $122.8K | $168.4K | $187.9K | $105.8K | $105.7K | $89.9K | $206.6K | $265.0K | $337.8K | $116.9K | |
| Current Assets | · | · | · | $6M | $5M | · | $6M | · | · | · | $7M | $9M | $7M | · | $11M | $9M | |
| Total Assets | $10M | $8M | $6M | · | · | $4M | · | $7M | $9M | $8M | · | · | · | $9M | · | $9M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $473.9K | |
| Current Liabilities | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $473.9K | |
| Total Liabilities | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $473.9K | |
| Common Stock | $3.4K | $2.3K | $1.8K | $1.5K | $22.4K | $852 | $16.8K | $16.0K | $15.8K | $14.5K | $13.0K | $13.0K | $11.7K | $11.6K | $11.6K | $10.3K | |
| Paid-in Capital | $84M | $81M | $77M | $75M | $72M | $68M | $67M | $65M | $64M | $58M | $52M | $51M | $47M | $46M | $45M | $41M | |
| Retained Earnings | $-77M | $-75M | $-74M | $-72M | $-69M | $-67M | $-65M | $-62M | $-58M | $-53M | $-48M | $-45M | $-42M | $-39M | $-35M | $-32M | |
| Stockholders' Equity | $7M | $5M | $4M | $4M | $2M | $615.1K | $3M | $3M | $6M | $5M | $4M | $6M | $5M | $7M | $10M | · | |
| Liabilities + Equity | $10M | $8M | $6M | $6M | $5M | $4M | $6M | $7M | $9M | $8M | $7M | $9M | $7M | $9M | $11M | $9M | |
| Shares Outstanding | 3,389,106 | 2,348,113 | 1,800,299 | 1,470,352 | 22,397,511 | 851,534 | 16,770,378 | 15,996,168 | 15,757,102 | 14,468,229 | 13,005,128 | 13,005,128 | 11,671,795 | 11,627,609 | 11,592,609 | 10,263,202 |
Fluxo de Caixa 4
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $258.3K | $294.8K | $294.8K | $324.2K | $333.6K | $345.2K | $345.2K | $1M | $894.5K | $833.3K | $833.3K | $806.5K | $733.5K | $697.0K | $697.0K | $716.7K | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-2M | $-2M | $-2M | $-1M | $-2M | $-2M | |
| Financing Cash Flow | $3M | $3M | $2M | $3M | $3M | $194.5K | $2M | $320.2K | $5M | $5M | $0 | · | · | $-1 | · | · | |
| Net Change in Cash | $2M | $2M | $-157.3K | $1M | $937.2K | $-2M | $-598.3K | $-3M | $1M | $421.9K | $-2M | $2M | $-2M | $-1M | $2M | $-2M |
Lucratividade 2
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.0% | · | -18.9% | · | · | · | · | -52.0% | -42.9% | · | · | · | · | · | · | -19.6% | |
| ROE | -36.1% | · | -63.2% | -64.2% | -51.7% | · | -85.5% | -85.5% | -77.4% | · | -45.5% | -110.8% | -109.3% | · | -72.5% | · |
Liquidez e Solvência 2
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 2.4 | 1.9 | · | 1.8 | · | · | · | 2.2 | 3.1 | 3.6 | · | 9.3 | 19.4 | |
| Quick Ratio | 3.7 | · | 2.4 | 2.3 | 1.9 | · | 1.7 | 2.0 | 2.9 | · | 2.2 | 3.0 | 3.5 | · | 9.0 | 19.2 |
Avaliação (TTM) 7
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-8M | · | $-9M | $-11M | $-13M | · | $-14M | $-15M | $-14M | · | $-13M | $-13M | $-12M | · | $-13M | $-14M | |
| Market Cap | $13M | · | $8M | $15M | $175M | · | $637M | $720M | $772M | · | $390M | $689M | $808M | · | $696M | $778M | |
| P/E | -0.6 | · | -0.6 | -1.0 | -0.9 | · | -4.1 | -7.5 | -46.7 | · | -27.5 | -47.7 | -63.5 | · | -46.2 | -48.9 | |
| P/B | 1.8 | · | 2.1 | 4.2 | 75.6 | · | 239.2 | 210.0 | 128.7 | · | 99.2 | 110.9 | 152.1 | · | 71.2 | · | |
| P / Tangible Book | 1.8 | · | 2.1 | 4.2 | 75.6 | · | 239.2 | 210.0 | 128.7 | · | 99.2 | 110.9 | 152.1 | · | 71.2 | · | |
| P / Cash Flow | -8.9 | · | · | · | -85.2 | · | · | · | -252.1 | · | · | · | -417.9 | · | · | · | |
| Earnings Yield | -158.8% | · | -155.7% | -104.3% | -116.0% | · | -24.2% | -13.4% | -2.1% | · | -3.6% | -2.1% | -1.6% | · | -2.2% | -2.0% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Lucro líquido | $-8M | $-14M | $-15M | $-12M | $-13M |
| EPS Diluído | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de Liquidez Seca | 3.1 | 1.1 | 2.5 | 4.4 | 15.4 |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.